US3894541A - Method of treating hydrocephalus - Google Patents

Method of treating hydrocephalus Download PDF

Info

Publication number
US3894541A
US3894541A US446420A US44642074A US3894541A US 3894541 A US3894541 A US 3894541A US 446420 A US446420 A US 446420A US 44642074 A US44642074 A US 44642074A US 3894541 A US3894541 A US 3894541A
Authority
US
United States
Prior art keywords
catheter
vein
blood
neck
venous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US446420A
Inventor
Ismail Lotfy El-Shafei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US446420A priority Critical patent/US3894541A/en
Application granted granted Critical
Publication of US3894541A publication Critical patent/US3894541A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84—Drainage tubes; Aspiration tips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09—Guide wires
    • A61M25/09016—Guide wires with mandrils
    • A61M25/09025—Guide wires with mandrils with sliding mandrils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves

Definitions

  • the catheter consists of a tubing of soft tissue-compatible material and is provided with a simple check valve to prevent reflux of blood.
  • This invention relates generally to the surgical arts. and more particularly to a method and apparatus for treating hydrocephalus by establishing a ventricle venous shunt between the lateral ventricle and the proximal portion of a ligated neck vein.
  • a catheter In treating hydrocephalus using one of these valve systems a catheter is thrust into the ventricles of the brain in order to drain unwanted fluid therefrom. and is then led through the jugular vein into the heart so that the fluid from the ventricles enters the blood stream and is disposed of by the process of purification of the blood.
  • the shunting catheter which lies directly in the blood stream acts as a foreign body and may excite blood clotting, venous thrombosis and embolic complications.
  • the purpose of the shunt system and the catheter of this invention is in general to avoid all the above difficulties and complications by providing means for treating hydrocephalus by using the catheter of this invention to establish a connection between the cerebral ventricles and the proximal segment of a li gated neck vein, e.g., the external jugular vein (EJV) or the common facial vein (CFV).
  • EJV external jugular vein
  • CMV common facial vein
  • This method of establishing the ventri cle venous connection commprised inserting the ventricle end of the catheter into the lateral ventricle such that no CSF could leak from the dural hole made for the tube insertion into the ventricle, and the open venous end of the tube was to be inserted into the proximal segment ofa ligated neck vein against the direction of blood flow.
  • the catheter disclosed in the instant application represents an improvement over the catheter as disclosed in the aforementioned co-pending application. Moreover. the instant application includes further details and elaboration of the method disclosed in the aforementioned co-pending application.
  • VV ventriculo venous
  • Another object of this invention is to provide a cathcter made of tissue-compatible material having means for easy insertion into the cerebral ventricle through a small dural hole.
  • Another object of this invention is to provide a catheter as abovedescribed having means for protection of the drainage apertures in the wall of the catheter tubing at its ventricular end.
  • Still another object of this invention is to provide a catheter having means which will facilitate a watertight closure of the dura mater around the catheter.
  • Yet another object of this invention is to provide a catheter as above described having means for introducing a stylet therein to provide an axial force for inserting the catheter into the ventricle.
  • a further object of this invention is to provide a catheter as above-described having means for recording pressures in the ventricles and in the venous side of the ⁇ "V connection.
  • Still another object of this invention is to provide a catheter as above-described having means for monitoring the patency ofthe shunt system provided by the connection.
  • Another object of this invention is to provide a catheter as abovedescribed having means for prevention of reflux of blood therein.
  • Another object of this invention is to provide a catheter as above-described having the provision of an available extra 5 ems to the length of the catheter which will accommodate variations in the length of body segment bridged by the catheter.
  • a further object of this invention is to provide a catheter as above-described having resistance to kinking at the sites of curves in the course of the catheter as well as resistance to being pulled out of the vein due to movements of the head and neck.
  • FIG. I is a schematic illustration of the head and neck of an individual. and illustrates the ventriculo venous sbunt (VV) of this invention showing the catheter in its place to establish the connection between the cerebral ventricle and the proximal segment of a ligated EJV;
  • VV ventriculo venous sbunt
  • FIG. 2 is a plan view of the catheter of this invention, having portions thereof cut away for clarity to illustrate internal portions thereof;
  • FIG. 2 a catheter made of soft silicone rubber or any other tissue-compatible material and has a simple. unidirectional check valve (V) incorporated near its middle.
  • the catheter can be divided into a ventricular segment and a venous segment between which the check valve (V) is incorporated.
  • the ventricular segment extends from the ventricular tip to the check valve and comprises the following: l) a ventricular tip (A) which is firm blind pointed with a depression (D) on its inside for lodging a stylet (S).
  • FIG. 3. which is used to provide an axial force for inserting the catheter into the ventricle.
  • This arrangement keeps the pointed tip pointing forwards and permits its easy insertion through a tiny dural hole; (2) intake apertures (H) in the wall of the first two centimeters of the ventricular end of the catheter which permit the flow oI'CSF from the ventricle into the catheter; (3) soft silicone rubber flanges (Fl) attached to the catheter wall and projecting between the apertures (H) protect them by bending and closing them during insertion of the catheter into the ventricle and reopen inside the ventricle thereby keeping the apertures away from the wall of the ventricle and from the choroid plexus; (4) a single soft silicone rubber flange (F2) is attached to the catheter at a distance approximately 10 ems from the ventricular tip.
  • the flange (F2) marks the extent of catheter to be inserted through the dural hole and is also used for obtaining a watertight closure of the dura mater around the catheter either by using Histacryl to stick the flange to the dura mater or by suturing it.
  • This flange (F2) can be made of a larger diameter than the flanges (Fl protecting the apertures (H); (5) a few centimeters beyond the flange (F2) 21 side tube (T) projects from the main catheter at an angle of about 45.
  • the side tube is of the same thickness and bore as the rest of the catheter and measures about 4 cms in length. It is used as a means for inserting the stylet (S FIG. 3, into the ventricular segment of the catheter.
  • the side tube (T) is tied after the satisfactory establishment of the VV connection and can be used later to check the patency of the shunt system if such a step is ever needed; (6) two strong side flanges (F3) with holes are attached to the catheter at the point of its junction with the side tube.
  • the flanges (F3) are used for fixing the catheter to the periosteum by sutures (FIG. 1, Lig. 3).
  • V The simple check valve (V) which separates the ventricular from the venous segment of the catheter lies a few centimeters beyond the side tube (T) This valve prevents reflux of blood into the catheter but it has nothing to do with the regulation of the intraventricular pressure (IVP).
  • IVP intraventricular pressure
  • the venous segment of the tube extends from the check valve till the venous end and consists of: (l the venous end of the catheter which includes a bulbous portion (G) so as to prevent its slipping out from the neck vein due to movements of the neck.
  • the outside diameter of the bulbous venous end (G) of the catheter is approximately double that of the main portion of the catheter and therefore it is unlikely to slip out from the vein when a ligature is tied around the vein to hold the tube inside it; (2) a kink-proof segment which extends from the bulbous venous end for a distance of about 15 cms.
  • a spiral wire is incorporated into the venous portion of the catheter to prevent kinking and occlusion of the catheter at the point where it curves up to enter into the tied neck vein; (3) the other half ofthe venous segment has an expansible telescoping segment (TS) which can provide an extension of the tube an extra length of about 5 cms. Such a length is needed to allow for variations in the length of body segment bridged by the shunting catheter as occurs during movements of the head or due to an increase in length of the individual.
  • TS expansible telescoping segment
  • Exemplary dimensions of the elements of this invention may be as follows: Its length may be approximately 37 ems, the outside diameter of the tubing may be approximately 2.2 mms, the lumen may be approximately 1 mm. The distance between the ventricular tip and the flange (F2 in FIG. 2) may be approximately IO cms. from the flange (F2) to the side tube (T) may be ap proximately 3 cms and from the side tube to the valve (V) may be approximately 3 ems. The segment of tube between the check valve (V) and the bulbous venous end (G) of the catheter may be approximately 20 cms.
  • a spiral wire (Sp.W) or any anti-kinking system is incorporated in the 15 cms of tubing next to the bulbous venous end (G) while in the remaining 10 cms of tubing between the end of the spiral wire and the check valve the telescoping segment (TS) is incorporated into the catheter.
  • Sp.W spiral wire
  • G bulbous venous end
  • TS telescoping segment
  • VV ventriculo venous connection
  • a neck vein. cg. the EJV. is tied (Lig. l in FIG. 1) above the valve in its lower end, the pressure in the proximal segment of the vein rises to about +8 to 9 cms saline.
  • the catheter of this invention FIG. 2 is used to establish a connection between the cerebral ventricle and the proximal segment of the ligated EJV provided that CSF loss or leakage is not allowed to occur, a closed system will be established one side of which will be the cerebral ventricles and the other side will be the vein segment BC in FIG. 1.
  • the CSF Since the pressure in the hydrocephalic ventricles is much higher than the pressure in the vein segment BC. the CSF will flow from the cerebral ventricle. through the shunt tube and through the vein segment BC, washing the blood away from it and converting it into an extension to the shunt tube. The CSF enters the venous circulation at point C via the tributaries of the tied vein. The flow of CSF continues until a state of equilibrium between the pressures in the cerebral ventricles and in the vein segment BC takes place, and the CSF will flow thereafter into the venous circulation at a rate corresponding to the rate of its formation.
  • Establishing the VV connection in this way fulfills the following advantages: (I the vein segment BC will be converted into an extension to the shunt tube connecting the venous end of the catheter (at point B) to the circulating venous blood at point C. This vein segment will be full of CSF which acts as a barrier preventing contact between the catheter and the circulating blood; (2) the higher pressure created in the proximal segment of the tied vein provides a resistance to the flow of CSF and maintains the intraventricular pressure (IVP) at a level higher than the pressure in the vein segment by an amount that will depend on the rate of CSF formation.
  • the average lVP after establishing the connection is around +12 ems saline which is within normal limits.
  • the ventricular end of the catheter is inserted into the cerebral ventricle via a small hole in the dura mater which is exposed through a posterior temporal burr hole.
  • the sty'let (S). which is approximately ems long wire of a thickness less than the bore of the catheter (approximately 0.5mm is introduced via the side tube and passed into the ventricular segment of the catheter to lodge in the depression (D) on the inside of the ventricular tip (A). and is used to provide an axial force to insert the catheter into the ventricle until the soft silicone flange (F2 in FIG. 2) Comes into contact with the dura mater.
  • the flange (F2) is fixed to the dura mater using Histacryl or sutures (Lig. 3) so as to obtain a watertight closure of dura mater around the catheter.
  • the side flanges (F3) at the junction of the side tube with the main catheter are fixed to the periosteum by sutures.
  • the venous end of the tube is passed through a tunnel under the skin just posterior to the mastoid process and emerges in a neck wound made to expose the EJV or the CFV.
  • the vein chosen for the anastomosis is tied (if the EJV is used it is tied above the valve in its lower end, ifthe EJV is slender the CFV can be used and it is tied at its entrance into the internal jugular vein).
  • a side opening is made into the vein wall proximal to the tied ligature and the bulbous venous end (G) of the catheter is inserted into the vein in an upward direction for a distance of about 1 cm (FIG. 1) against the direction of the blood stream.
  • the side opening (SL) in the vein wall is closed around the catheter using vascular sutures and a ligature (Lig.
  • a stitch (Lig. 5) is taken to anchor the catheter to the deep l'acia near the vein opening. The force ot'any pull on the catheter will be expended at the anchoring stitch (Lig. 5) and will not be effective at the catheter vein junction.
  • clamps are applied on the side tube and on the venous segment ofthe catheter to prevent CSF loss. Al'ter establishing the connection.
  • the side tube can be connected to a manometer so as to record the pressure in the cerebral ventricle or in the vein.
  • the side tube is closed (Lig. 2) and fixed to the periosteum before closing the skin wounds.
  • a method of treating hydrocephalus comprising the steps of establishing a connection between the lateral ventricle and a ligated neck vein using a catheter having a ventricular end and a venous end. eliminating the syphonage force which develops with conventional valve systems when the patient assumes the upright position. and preventing contact between the shunting catheter and the circulating blood by inserting the venous end of the catheter into the proximal segment of the ligated neck vein against the direction of blood flow.

Abstract

This disclosure relates to a catheter and method for its use to establish a connection between the cerebral ventricles and the proximal segment of a ligated neck vein for treating hydrocephalus. This method for shunting the cerebrospinal fluid (CSF) to the venous circulation prevents blood from coming into contact with the shunt tube and prevents a syphonage force from developing when the patient assumes the upright position. The catheter consists of a tubing of soft tissue-compatible material and is provided with a simple check valve to prevent reflux of blood. It has a side tube and it is also provided with means for: 1) easy insertion into the ventricle; 2) protection of the intake apertures; 3) watertight closure of the dura mater around it; 4) resistance to kinking; 5) provision of an available extra length of 5 cms; and 6) resistance to being pulled out of the neck vein due to movements of the head and neck.

Description

United States Patent El-Shafei 1 July 15, 1975 METHOD OF TREATING I'IYDROCEPHALUS [5 7] ABSTRACT [76] Inventor: Ismail Lotly El-Sh f i, 9( Ah d This disclosure relates to a catheter and method for its Heshmat str zamalik c i Egy use to establish a connection between the cerebral ventricles and the proximal segment of a ligated neck [22] Filed vein for treating hydrocephalus. This method for Appl. No; 446,420
Primary ExaminerDalton L. Truluck Attorney. Agenl. ur FirmWigman & Cohen shunting the cerebrospinai fluid (CSF) to the venous circulation prevents blood from coming into contact with the shunt tube and prevents a syphonage force from developing when the patient assumes the upright position. The catheter consists of a tubing of soft tissue-compatible material and is provided with a simple check valve to prevent reflux of blood. it has a side tube and it is also provided with means for: l) easy insertion into the ventricle; 2) protection of the intake apertures; 3) watertight closure of the dura mater around it; 4) resistance to kinking; 5) provision of an available extra length of 5 cms; and 6) resistance to being pulled out of the neck vein due to movements of the head and neck.
I Claim, 3 Drawing Figures METHOD OF TREATING HYDROCEPHALUS This invention relates generally to the surgical arts. and more particularly to a method and apparatus for treating hydrocephalus by establishing a ventricle venous shunt between the lateral ventricle and the proximal portion of a ligated neck vein.
BACKGROUND OF lNVENTlON At the present time. there are several valve systems to provide vcntriculo atrial shunts to drain CSF from the ventricles of the brain into the venous blood stream. Examples of these systems are: U.S. Pat. No 2.969.066 (Holter et al.); U.S. Pat. No. 3.020.913 (Hyer-Pudcnz); and U.S. Pat. No. 3 288.l42 (Hakim).
In treating hydrocephalus using one of these valve systems a catheter is thrust into the ventricles of the brain in order to drain unwanted fluid therefrom. and is then led through the jugular vein into the heart so that the fluid from the ventricles enters the blood stream and is disposed of by the process of purification of the blood.
Two main disadvantages encountered with conven' tional shunt systems are:
l. the development of a syphonage force whenever the patient assumes the upright position. This force corresponds to the height of the CSF column in the shunting catheter and eventually causes excessive ventricular drainage which may lead to the development of intracranial hacmorrhage and/or collapse of the cerebral ventricles increasing the chances of blockage of the ventricular end of the shunting catheter;
2. the shunting catheter which lies directly in the blood stream acts as a foreign body and may excite blood clotting, venous thrombosis and embolic complications.
Therefore. as disclosed in co-pending application Ser. No. 316,995. the purpose of the shunt system and the catheter of this invention is in general to avoid all the above difficulties and complications by providing means for treating hydrocephalus by using the catheter of this invention to establish a connection between the cerebral ventricles and the proximal segment of a li gated neck vein, e.g., the external jugular vein (EJV) or the common facial vein (CFV).
In the aforementioned co-pending application Ser. No. 3 I 6,995 it is disclosed that the reason for the reflux of blood into the venous end of a non-valved shunting tube is the fact that there is a reduction in the suction effect exerted on the CSF caused by the running blood in the veins during periods of high intrathoracic pressure, as compared with the suction effect during periods of normal intrathoraeic pressure. Accordingly. a catheter and method for its use was disclosed which could be inserted into the vein in such a way as to prevent the suction effect of the running blood from exert ing its effect on the CSF so that the blood would not regurgitate into the tube during periods of high intrathoracic pressure. This method of establishing the ventri cle venous connection commprised inserting the ventricle end of the catheter into the lateral ventricle such that no CSF could leak from the dural hole made for the tube insertion into the ventricle, and the open venous end of the tube was to be inserted into the proximal segment ofa ligated neck vein against the direction of blood flow. The catheter disclosed in the instant application represents an improvement over the catheter as disclosed in the aforementioned co-pending application. Moreover. the instant application includes further details and elaboration of the method disclosed in the aforementioned co-pending application.
Accordingly. it is a primary object of this invention to provide a method for establishing a ventriculo venous (VV) connection to the proximal segment ofa ligated neck vein which will avoid most ofthe difficulties and complications encountered in treating hydrocephalus by the conventional ventriculo-atrial drainage systems More particularly. it is an object of this invention to provide a catheter which will facilitate establishing the aforementioned \v'V connection.
Another object of this invention is to provide a cathcter made of tissue-compatible material having means for easy insertion into the cerebral ventricle through a small dural hole.
Another object of this invention is to provide a catheter as abovedescribed having means for protection of the drainage apertures in the wall of the catheter tubing at its ventricular end.
Still another object of this invention is to provide a catheter having means which will facilitate a watertight closure of the dura mater around the catheter.
Yet another object of this invention is to provide a catheter as above described having means for introducing a stylet therein to provide an axial force for inserting the catheter into the ventricle.
A further object of this invention is to provide a catheter as above-described having means for recording pressures in the ventricles and in the venous side of the \"V connection.
Still another object of this invention is to provide a catheter as above-described having means for monitoring the patency ofthe shunt system provided by the connection.
Another object of this invention is to provide a catheter as abovedescribed having means for prevention of reflux of blood therein.
Another object of this invention is to provide a catheter as above-described having the provision of an available extra 5 ems to the length of the catheter which will accommodate variations in the length of body segment bridged by the catheter.
A further object of this invention is to provide a catheter as above-described having resistance to kinking at the sites of curves in the course of the catheter as well as resistance to being pulled out of the vein due to movements of the head and neck.
With the above and other objects in view that may hereinafter become apparent. the nature of the invention may be more clearly understood by reference to the several views illustrated in the accompanying drawings. the following detailed description thereof. and the appended claimed subject matter:
IN THE DRAWINGS FIG. I is a schematic illustration of the head and neck of an individual. and illustrates the ventriculo venous sbunt (VV) of this invention showing the catheter in its place to establish the connection between the cerebral ventricle and the proximal segment of a ligated EJV;
FIG. 2 is a plan view of the catheter of this invention, having portions thereof cut away for clarity to illustrate internal portions thereof;
Referring now to the drawings in detail. there is illustrated in FIG. 2 a catheter made of soft silicone rubber or any other tissue-compatible material and has a simple. unidirectional check valve (V) incorporated near its middle. For purposes of description. the catheter can be divided into a ventricular segment and a venous segment between which the check valve (V) is incorporated. The ventricular segment extends from the ventricular tip to the check valve and comprises the following: l) a ventricular tip (A) which is firm blind pointed with a depression (D) on its inside for lodging a stylet (S). FIG. 3. which is used to provide an axial force for inserting the catheter into the ventricle. This arrangement keeps the pointed tip pointing forwards and permits its easy insertion through a tiny dural hole; (2) intake apertures (H) in the wall of the first two centimeters of the ventricular end of the catheter which permit the flow oI'CSF from the ventricle into the catheter; (3) soft silicone rubber flanges (Fl) attached to the catheter wall and projecting between the apertures (H) protect them by bending and closing them during insertion of the catheter into the ventricle and reopen inside the ventricle thereby keeping the apertures away from the wall of the ventricle and from the choroid plexus; (4) a single soft silicone rubber flange (F2) is attached to the catheter at a distance approximately 10 ems from the ventricular tip. The flange (F2) marks the extent of catheter to be inserted through the dural hole and is also used for obtaining a watertight closure of the dura mater around the catheter either by using Histacryl to stick the flange to the dura mater or by suturing it. This flange (F2) can be made of a larger diameter than the flanges (Fl protecting the apertures (H); (5) a few centimeters beyond the flange (F2) 21 side tube (T) projects from the main catheter at an angle of about 45. The side tube is of the same thickness and bore as the rest of the catheter and measures about 4 cms in length. It is used as a means for inserting the stylet (S FIG. 3, into the ventricular segment of the catheter. It can also be connected to a manometer to record the pressure in the ventricle or in the vein side of the connection during the operation. The side tube (T) is tied after the satisfactory establishment of the VV connection and can be used later to check the patency of the shunt system if such a step is ever needed; (6) two strong side flanges (F3) with holes are attached to the catheter at the point of its junction with the side tube. The flanges (F3) are used for fixing the catheter to the periosteum by sutures (FIG. 1, Lig. 3).
The simple check valve (V) which separates the ventricular from the venous segment of the catheter lies a few centimeters beyond the side tube (T) This valve prevents reflux of blood into the catheter but it has nothing to do with the regulation of the intraventricular pressure (IVP).
The venous segment of the tube extends from the check valve till the venous end and consists of: (l the venous end of the catheter which includes a bulbous portion (G) so as to prevent its slipping out from the neck vein due to movements of the neck. The outside diameter of the bulbous venous end (G) of the catheter is approximately double that of the main portion of the catheter and therefore it is unlikely to slip out from the vein when a ligature is tied around the vein to hold the tube inside it; (2) a kink-proof segment which extends from the bulbous venous end for a distance of about 15 cms. A spiral wire (Sp.W) is incorporated into the venous portion of the catheter to prevent kinking and occlusion of the catheter at the point where it curves up to enter into the tied neck vein; (3) the other half ofthe venous segment has an expansible telescoping segment (TS) which can provide an extension of the tube an extra length of about 5 cms. Such a length is needed to allow for variations in the length of body segment bridged by the shunting catheter as occurs during movements of the head or due to an increase in length of the individual.
Exemplary dimensions of the elements of this invention may be as follows: Its length may be approximately 37 ems, the outside diameter of the tubing may be approximately 2.2 mms, the lumen may be approximately 1 mm. The distance between the ventricular tip and the flange (F2 in FIG. 2) may be approximately IO cms. from the flange (F2) to the side tube (T) may be ap proximately 3 cms and from the side tube to the valve (V) may be approximately 3 ems. The segment of tube between the check valve (V) and the bulbous venous end (G) of the catheter may be approximately 20 cms. A spiral wire (Sp.W) or any anti-kinking system is incorporated in the 15 cms of tubing next to the bulbous venous end (G) while in the remaining 10 cms of tubing between the end of the spiral wire and the check valve the telescoping segment (TS) is incorporated into the catheter. Of course. depending on the intended use and the age of the patient, these dimensions and arrangements can be varied at will.
The theoretical basis for the suggested ventriculo venous (VV) connection (FIG. 1) is as follows: If a neck vein. cg. the EJV. is tied (Lig. l in FIG. 1) above the valve in its lower end, the pressure in the proximal segment of the vein rises to about +8 to 9 cms saline. If the catheter of this invention (FIG. 2) is used to establish a connection between the cerebral ventricle and the proximal segment of the ligated EJV provided that CSF loss or leakage is not allowed to occur, a closed system will be established one side of which will be the cerebral ventricles and the other side will be the vein segment BC in FIG. 1. Since the pressure in the hydrocephalic ventricles is much higher than the pressure in the vein segment BC. the CSF will flow from the cerebral ventricle. through the shunt tube and through the vein segment BC, washing the blood away from it and converting it into an extension to the shunt tube. The CSF enters the venous circulation at point C via the tributaries of the tied vein. The flow of CSF continues until a state of equilibrium between the pressures in the cerebral ventricles and in the vein segment BC takes place, and the CSF will flow thereafter into the venous circulation at a rate corresponding to the rate of its formation.
Establishing the VV connection in this way fulfills the following advantages: (I the vein segment BC will be converted into an extension to the shunt tube connecting the venous end of the catheter (at point B) to the circulating venous blood at point C. This vein segment will be full of CSF which acts as a barrier preventing contact between the catheter and the circulating blood; (2) the higher pressure created in the proximal segment of the tied vein provides a resistance to the flow of CSF and maintains the intraventricular pressure (IVP) at a level higher than the pressure in the vein segment by an amount that will depend on the rate of CSF formation. The average lVP after establishing the connection is around +12 ems saline which is within normal limits. This means that no excessive ventricular decompression takes place; (3) reflux of blood into the catheter cannot occur because of a simple check valve (V in FIGS. 1 and 2) incorporated into it. Dissimilar from other valves used in conventional ventriculo-atrial catheters. the valve in this invention has nothing to do with the regulation of the WP. its only job is to prevent reflux of blood; (4) a syphonage effect does not occur when the patient assumes the upright position because of the hydrostatic pressure of the blood in the veins of the head and neck.
METHODS OF ESTABLlSHlNG THE VV CONNECTION The ventricular end of the catheter is inserted into the cerebral ventricle via a small hole in the dura mater which is exposed through a posterior temporal burr hole. The sty'let (S). which is approximately ems long wire of a thickness less than the bore of the catheter (approximately 0.5mm is introduced via the side tube and passed into the ventricular segment of the catheter to lodge in the depression (D) on the inside of the ventricular tip (A). and is used to provide an axial force to insert the catheter into the ventricle until the soft silicone flange (F2 in FIG. 2) Comes into contact with the dura mater. The flange (F2) is fixed to the dura mater using Histacryl or sutures (Lig. 3) so as to obtain a watertight closure of dura mater around the catheter. The side flanges (F3) at the junction of the side tube with the main catheter are fixed to the periosteum by sutures. The venous end of the tube is passed through a tunnel under the skin just posterior to the mastoid process and emerges in a neck wound made to expose the EJV or the CFV. The vein chosen for the anastomosis is tied (if the EJV is used it is tied above the valve in its lower end, ifthe EJV is slender the CFV can be used and it is tied at its entrance into the internal jugular vein). A side opening is made into the vein wall proximal to the tied ligature and the bulbous venous end (G) of the catheter is inserted into the vein in an upward direction for a distance of about 1 cm (FIG. 1) against the direction of the blood stream. The side opening (SL) in the vein wall is closed around the catheter using vascular sutures and a ligature (Lig. 4) is tied around the vein proximal to the bulbous venous end ((3) of the catheter to prevent it slipping out of the vein. As a further measure against pulling of the catheter out of the vein during movements of the neck. a stitch (Lig. 5) is taken to anchor the catheter to the deep l'acia near the vein opening. The force ot'any pull on the catheter will be expended at the anchoring stitch (Lig. 5) and will not be effective at the catheter vein junction. Throughout the procedure clamps are applied on the side tube and on the venous segment ofthe catheter to prevent CSF loss. Al'ter establishing the connection. the side tube can be connected to a manometer so as to record the pressure in the cerebral ventricle or in the vein. The side tube is closed (Lig. 2) and fixed to the periosteum before closing the skin wounds.
While the invention has been specifically illustrated and described herein with reference to a preferred embodiment thereof. it is contemplated that minor modifications could be made therein without departing from the spirit of the invention.
1 claim:
1. A method of treating hydrocephalus comprising the steps of establishing a connection between the lateral ventricle and a ligated neck vein using a catheter having a ventricular end and a venous end. eliminating the syphonage force which develops with conventional valve systems when the patient assumes the upright position. and preventing contact between the shunting catheter and the circulating blood by inserting the venous end of the catheter into the proximal segment of the ligated neck vein against the direction of blood flow.

Claims (1)

1. A method of treating hydrocephalus comprising the steps of establishing a connection between the lateral ventricle and a ligated neck vein using a catheter having a ventricular end and a venous end, eliminating the syphonage force which develops with conventional valve systems when the patient assumes the upright position, and preventing contact between the shunting catheter and the circulating blood by inserting the venous end of the catheter into the proximal segment of the ligated neck vein against the direction of blood flow.
US446420A 1974-02-27 1974-02-27 Method of treating hydrocephalus Expired - Lifetime US3894541A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US446420A US3894541A (en) 1974-02-27 1974-02-27 Method of treating hydrocephalus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US446420A US3894541A (en) 1974-02-27 1974-02-27 Method of treating hydrocephalus

Publications (1)

Publication Number Publication Date
US3894541A true US3894541A (en) 1975-07-15

Family

ID=23772508

Family Applications (1)

Application Number Title Priority Date Filing Date
US446420A Expired - Lifetime US3894541A (en) 1974-02-27 1974-02-27 Method of treating hydrocephalus

Country Status (1)

Country Link
US (1) US3894541A (en)

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004667A1 (en) * 1978-04-07 1979-10-17 Precimed S.A. Cardiac probe
US4378797A (en) * 1980-04-14 1983-04-05 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4446154A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445887A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445888A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445886A (en) * 1980-04-14 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4446155A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445500A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445514A (en) * 1980-04-14 1984-05-01 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4451251A (en) * 1982-03-03 1984-05-29 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4450841A (en) * 1982-03-03 1984-05-29 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
FR2539298A1 (en) * 1983-01-14 1984-07-20 Descartes Paris V Universite R Device for the treatment of hydrocephalus with an improved catheter
FR2539299A1 (en) * 1983-01-14 1984-07-20 Descartes Paris V Universite R HYDROCEPHALY TREATMENT DEVICE WITH VARIABLE IMPEDANCE FILTER
EP0117695A2 (en) * 1983-02-23 1984-09-05 BAXTER INTERNATIONAL INC. (a Delaware corporation) External ventricular drainage assembly
US4475898A (en) * 1982-04-26 1984-10-09 American Hospital Supply Corporation Fetal ventriculo-amniotic shunt
EP0185865A1 (en) * 1984-12-18 1986-07-02 Intermedicat Gmbh Implantable intraperitoneal catheter
US4598579A (en) * 1984-10-23 1986-07-08 Cordis Corporation Portable instrument to test pressure/flow of ventricular shunt valves
US4631051A (en) * 1984-09-24 1986-12-23 Cordis Corporation Ventricular amniotic shunt and introducer system
US4657532A (en) * 1985-07-19 1987-04-14 Thomas Jefferson University Intra-peritoneal perfusion of oxygenated fluorocarbon
US4686085A (en) * 1980-04-14 1987-08-11 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4758431A (en) * 1980-04-14 1988-07-19 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4795437A (en) * 1987-01-29 1989-01-03 Pudenz-Schulte Medical Research Corporation Siphon control device
US4795423A (en) * 1980-04-14 1989-01-03 Thomas Jefferson University Oxygenated perfluorinated perfusion of the ocular globe to treat ischemic retinopathy
US4830849A (en) * 1980-04-14 1989-05-16 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4840617A (en) * 1980-04-14 1989-06-20 Thomas Jefferson University Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
EP0542999A1 (en) * 1991-06-07 1993-05-26 Taut Inc Uncollapsible catheter and methods.
WO1993021973A1 (en) * 1992-04-24 1993-11-11 Loma Linda University Medical Center Cerebrospinal fluid shunt capable of minimal invasive revision
US5846220A (en) * 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US6283934B1 (en) 1996-09-18 2001-09-04 Sinu Shunt A/S Device for the treatment of hydrocephalus
WO2002036193A1 (en) * 2000-10-30 2002-05-10 Technovobis Ab System and method for physiological drainage
US6594880B2 (en) 1995-04-28 2003-07-22 Medtronic, Inc. Intraparenchymal infusion catheter system
US20040211433A1 (en) * 2003-04-24 2004-10-28 Medtronic Vascular, Inc. Method of maintaining patency of opening in third ventricle floor
US20050096580A1 (en) * 2003-10-31 2005-05-05 Ari Moskowitz Apparatus and method for retrograde placement of sagittal sinus drainage catheter
FR2861601A1 (en) * 2003-10-31 2005-05-06 Medtronic Inc APPARATUS AND METHOD FOR RETROGRADE PLACEMENT OF A SINUS SAGITTAL DRAINAGE CATHETER
US6905474B2 (en) 2000-09-11 2005-06-14 Csf Dynamic A/S Fluid shunt system and a method for the treatment of hydrocephalus
US20060074388A1 (en) * 2004-09-30 2006-04-06 Alan Dextradeur Fluid management flow implants of improved occlusion resistance
US7189222B2 (en) 1996-04-30 2007-03-13 Medtronic, Inc. Therapeutic method of treatment of alzheimer's disease
EP2666506A1 (en) * 2012-05-23 2013-11-27 DePuy Synthes Products, LLC Catheter curvature braces and methods of using same
CN104383616A (en) * 2014-12-10 2015-03-04 中国人民解放军第四军医大学 Drainage device used for subdural hematoma
WO2016070147A1 (en) * 2014-10-31 2016-05-06 Cerevasc, Llc Methods and systems for treating hydrocephalus
WO2017066389A1 (en) * 2015-10-14 2017-04-20 University Of Pittsburgh-Of The Commonwealth System Of Higher Education A novel low-profile ventriculoamniotic shunt for fetal aqueductal stenosis
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9737697B2 (en) 2009-01-29 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US10272230B2 (en) 2015-10-30 2019-04-30 Cerevasc, Llc Systems and methods for treating hydrocephalus
US10322267B2 (en) 2013-03-15 2019-06-18 Carlos A. Hakim Externally programmable valve assembly
US10625061B2 (en) 2016-06-20 2020-04-21 Csf-Dynamics A/S Shunt device and a method for shunting cerebrospinal fluid
US11013900B2 (en) 2018-03-08 2021-05-25 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US11278708B2 (en) 2014-01-15 2022-03-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
RU2789524C2 (en) * 2022-05-20 2023-02-06 Артем Дмитриевич Донской Method for endoscopic drainage of poster sections of both lateral ventricles
CN117282004A (en) * 2023-11-24 2023-12-26 通桥医疗科技有限公司 Shunt for treating hydrocephalus and system thereof
WO2024020677A1 (en) * 2022-07-26 2024-02-01 Teresa Purzner Ventricular shunt system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3516410A (en) * 1968-01-03 1970-06-23 Salomon Hakim Cerebro-ventricular catheter
US3669094A (en) * 1970-07-06 1972-06-13 Heyer Schulte Corp Device and method for measuring intracranial pressure
US3738365A (en) * 1969-07-22 1973-06-12 R Schulte Spring reinforced extensible catheter
US3769982A (en) * 1971-09-24 1973-11-06 R Schulte Physiological drainage system with closure means responsive to downstream suction

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3516410A (en) * 1968-01-03 1970-06-23 Salomon Hakim Cerebro-ventricular catheter
US3738365A (en) * 1969-07-22 1973-06-12 R Schulte Spring reinforced extensible catheter
US3669094A (en) * 1970-07-06 1972-06-13 Heyer Schulte Corp Device and method for measuring intracranial pressure
US3769982A (en) * 1971-09-24 1973-11-06 R Schulte Physiological drainage system with closure means responsive to downstream suction

Cited By (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004667A1 (en) * 1978-04-07 1979-10-17 Precimed S.A. Cardiac probe
US4686085A (en) * 1980-04-14 1987-08-11 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4378797A (en) * 1980-04-14 1983-04-05 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4758431A (en) * 1980-04-14 1988-07-19 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4795423A (en) * 1980-04-14 1989-01-03 Thomas Jefferson University Oxygenated perfluorinated perfusion of the ocular globe to treat ischemic retinopathy
US4830849A (en) * 1980-04-14 1989-05-16 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445886A (en) * 1980-04-14 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4840617A (en) * 1980-04-14 1989-06-20 Thomas Jefferson University Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
US4445514A (en) * 1980-04-14 1984-05-01 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4450841A (en) * 1982-03-03 1984-05-29 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4451251A (en) * 1982-03-03 1984-05-29 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445500A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4446155A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445888A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4445887A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4446154A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4475898A (en) * 1982-04-26 1984-10-09 American Hospital Supply Corporation Fetal ventriculo-amniotic shunt
FR2539298A1 (en) * 1983-01-14 1984-07-20 Descartes Paris V Universite R Device for the treatment of hydrocephalus with an improved catheter
FR2539299A1 (en) * 1983-01-14 1984-07-20 Descartes Paris V Universite R HYDROCEPHALY TREATMENT DEVICE WITH VARIABLE IMPEDANCE FILTER
EP0115973A1 (en) * 1983-01-14 1984-08-15 Universite Rene Descartes, (Paris V) Device with a variable impedance filter for the treatment of hydrocephalus
US4605395A (en) * 1983-01-14 1986-08-12 Universite Rene Descartes (Paris V) Hydrocephaly treatment device including a variable impedance filter
EP0117695A3 (en) * 1983-02-23 1987-03-11 American Hospital Supply Corporation External ventricular drainage assembly
EP0117695A2 (en) * 1983-02-23 1984-09-05 BAXTER INTERNATIONAL INC. (a Delaware corporation) External ventricular drainage assembly
US4631051A (en) * 1984-09-24 1986-12-23 Cordis Corporation Ventricular amniotic shunt and introducer system
US4598579A (en) * 1984-10-23 1986-07-08 Cordis Corporation Portable instrument to test pressure/flow of ventricular shunt valves
EP0185865A1 (en) * 1984-12-18 1986-07-02 Intermedicat Gmbh Implantable intraperitoneal catheter
US4657532A (en) * 1985-07-19 1987-04-14 Thomas Jefferson University Intra-peritoneal perfusion of oxygenated fluorocarbon
US4795437A (en) * 1987-01-29 1989-01-03 Pudenz-Schulte Medical Research Corporation Siphon control device
EP0542999A4 (en) * 1991-06-07 1994-07-27 Taut Inc Uncollapsible catheter and methods
EP0542999A1 (en) * 1991-06-07 1993-05-26 Taut Inc Uncollapsible catheter and methods.
WO1993021973A1 (en) * 1992-04-24 1993-11-11 Loma Linda University Medical Center Cerebrospinal fluid shunt capable of minimal invasive revision
US5385541A (en) * 1992-04-24 1995-01-31 Loma Linda University Medical Center Cerebrospinal fluid shunt capable of minimal invasive revision
US6594880B2 (en) 1995-04-28 2003-07-22 Medtronic, Inc. Intraparenchymal infusion catheter system
US5846220A (en) * 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US6056725A (en) * 1996-04-30 2000-05-02 Medtronic, Inc. Therapeutic method for treatment of alzheimer's disease
US7189222B2 (en) 1996-04-30 2007-03-13 Medtronic, Inc. Therapeutic method of treatment of alzheimer's disease
US6503242B1 (en) 1996-04-30 2003-01-07 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US6283934B1 (en) 1996-09-18 2001-09-04 Sinu Shunt A/S Device for the treatment of hydrocephalus
US7118548B2 (en) 1996-09-18 2006-10-10 Sinu Shunt A/S Device for the treatment of hydrocephalus
US6905474B2 (en) 2000-09-11 2005-06-14 Csf Dynamic A/S Fluid shunt system and a method for the treatment of hydrocephalus
CN1299780C (en) * 2000-10-30 2007-02-14 泰克诺沃比斯股份公司 System and method for physiologial drainage
US20040087887A1 (en) * 2000-10-30 2004-05-06 Nilsson Per Erik System and method for physiological drainage
US7476211B2 (en) * 2000-10-30 2009-01-13 Technovobis Ab System and method for physiological drainage
WO2002036193A1 (en) * 2000-10-30 2002-05-10 Technovobis Ab System and method for physiological drainage
AU2002212884B2 (en) * 2000-10-30 2006-06-29 Technovobis Ab System and method for physiological drainage
US20040211433A1 (en) * 2003-04-24 2004-10-28 Medtronic Vascular, Inc. Method of maintaining patency of opening in third ventricle floor
US7530963B2 (en) * 2003-04-24 2009-05-12 Wisconsin Alumni Research Foundation Method of maintaining patency of opening in third ventricle floor
US7172571B2 (en) 2003-10-31 2007-02-06 Medtronic, Inc. Apparatus and method for retrograde placement of sagittal sinus drainage catheter
US20050096580A1 (en) * 2003-10-31 2005-05-05 Ari Moskowitz Apparatus and method for retrograde placement of sagittal sinus drainage catheter
FR2861601A1 (en) * 2003-10-31 2005-05-06 Medtronic Inc APPARATUS AND METHOD FOR RETROGRADE PLACEMENT OF A SINUS SAGITTAL DRAINAGE CATHETER
US20060074388A1 (en) * 2004-09-30 2006-04-06 Alan Dextradeur Fluid management flow implants of improved occlusion resistance
US20080214982A1 (en) * 2004-09-30 2008-09-04 Alan Dextradeur Fluid management flow implants of improved occlusion resistance
US7976517B2 (en) 2004-09-30 2011-07-12 Codman & Shurtleff, Inc. Fluid management flow implants of improved occlusion resistance
US8221392B2 (en) 2004-09-30 2012-07-17 Codman & Shurtleff, Inc. Fluid management flow implants of improved occlusion resistance
US9737697B2 (en) 2009-01-29 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US10112036B2 (en) 2009-01-29 2018-10-30 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9901707B2 (en) * 2012-05-23 2018-02-27 Integra Lifesciences Switzerland Sàrl Catheter curvature braces and methods of using same
US11065421B2 (en) * 2012-05-23 2021-07-20 Integra LifeSciences Switzerland Sarl Catheter curvature braces and methods of using same
EP2666506A1 (en) * 2012-05-23 2013-11-27 DePuy Synthes Products, LLC Catheter curvature braces and methods of using same
US20130317410A1 (en) * 2012-05-23 2013-11-28 Codman & Shurtleff, Inc. Catheter curvature braces and methods of using same
US11311704B2 (en) 2013-03-15 2022-04-26 Ceredyn Biotechnology Llc Externally programmable valve assembly
US10322267B2 (en) 2013-03-15 2019-06-18 Carlos A. Hakim Externally programmable valve assembly
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US10596357B2 (en) 2014-01-15 2020-03-24 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US11278708B2 (en) 2014-01-15 2022-03-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
JP2017538562A (en) * 2014-10-31 2017-12-28 セレバスク, エルエルシーCereVasc, LLC Method and system for treating hydrocephalus
WO2016070147A1 (en) * 2014-10-31 2016-05-06 Cerevasc, Llc Methods and systems for treating hydrocephalus
US10765846B2 (en) 2014-10-31 2020-09-08 CereVasc, Inc. Methods and systems for draining cerebrospinal fluid into the venous system
US9724501B2 (en) 2014-10-31 2017-08-08 Cerevasc, Llc Methods and systems for treating hydrocephalus
US10058686B2 (en) 2014-10-31 2018-08-28 Cerevasc, Llc Methods and systems for treating hydrocephalus
US9669195B2 (en) 2014-10-31 2017-06-06 Cerevasc, Llc Methods and systems for treating hydrocephalus
US9662479B2 (en) 2014-10-31 2017-05-30 Cerevasc, Llc Methods and systems for treating hydrocephalus
US10279154B2 (en) 2014-10-31 2019-05-07 Cerevasc, Llc Methods and systems for treating hydrocephalus
EP3753600A1 (en) * 2014-10-31 2020-12-23 CereVasc, Inc. Systems for treating hydrocephalus
US10307576B2 (en) 2014-10-31 2019-06-04 Cerevasc, Llc Systems and methods for deploying an implant in the vasculature
US9545505B2 (en) 2014-10-31 2017-01-17 Cerevasc, Llc Methods and systems for treating hydrocephalus
JP2019193826A (en) * 2014-10-31 2019-11-07 セレバスク, エルエルシーCereVasc, LLC Method and system for hydrocephalus treatment
US9387311B1 (en) 2014-10-31 2016-07-12 Cerevasc, Llc Methods and systems for treating hydrocephalus
CN104383616A (en) * 2014-12-10 2015-03-04 中国人民解放军第四军医大学 Drainage device used for subdural hematoma
CN104383616B (en) * 2014-12-10 2016-07-06 中国人民解放军第四军医大学 A kind of drainage system for subdural hematoma
WO2017066389A1 (en) * 2015-10-14 2017-04-20 University Of Pittsburgh-Of The Commonwealth System Of Higher Education A novel low-profile ventriculoamniotic shunt for fetal aqueductal stenosis
US10744308B2 (en) 2015-10-14 2020-08-18 University of Pittsburgh—of the Commonwealth System of Higher Education Low-profile ventriculoamniotic shunt for fetal aqueductal stenosis
US10307577B2 (en) 2015-10-30 2019-06-04 Cerevasc, Llc Systems and methods for deploying an implant in the vasculature
US10272230B2 (en) 2015-10-30 2019-04-30 Cerevasc, Llc Systems and methods for treating hydrocephalus
US10758718B2 (en) 2015-10-30 2020-09-01 CereVasc, Inc. Systems and methods for endovascularly accessing a subarachnoid space
US10625060B2 (en) 2016-06-20 2020-04-21 Csf-Dynamics A/S Shunt device and a method for shunting cerebrospinal fluid
US10625061B2 (en) 2016-06-20 2020-04-21 Csf-Dynamics A/S Shunt device and a method for shunting cerebrospinal fluid
US11013900B2 (en) 2018-03-08 2021-05-25 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US11850390B2 (en) 2018-03-08 2023-12-26 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US11951270B2 (en) 2020-08-05 2024-04-09 Cerevasc, Llc Systems and methods for endovascularly accessing a subarachnoid space
RU2789524C2 (en) * 2022-05-20 2023-02-06 Артем Дмитриевич Донской Method for endoscopic drainage of poster sections of both lateral ventricles
RU2796554C2 (en) * 2022-05-20 2023-05-25 Максим Александрович Кутин Method for ventriculostomy in bilateral obstruction of the interventricular hole
WO2024020677A1 (en) * 2022-07-26 2024-02-01 Teresa Purzner Ventricular shunt system
CN117282004A (en) * 2023-11-24 2023-12-26 通桥医疗科技有限公司 Shunt for treating hydrocephalus and system thereof
CN117282004B (en) * 2023-11-24 2024-01-26 通桥医疗科技有限公司 Shunt for treating hydrocephalus and system thereof

Similar Documents

Publication Publication Date Title
US3894541A (en) Method of treating hydrocephalus
US5967988A (en) Catheter having echogenicity enhancement
US4114603A (en) Intracranial pressure monitoring catheter
US3924633A (en) Apparatus and method for suprapubic catheterization
US5191898A (en) Method and assembly for measuring intracranial fluid characateristics
US5624396A (en) Longitudinally extendable infusion device
US3970089A (en) Cardiovascular catheter seal device
CN1223384C (en) Multi-lumen catheter with attachable hub
US6638268B2 (en) Catheter to cannulate the coronary sinus
US3492996A (en) Ventriculo-atrial shunt
US3654932A (en) Surgical drain for shunting fluid
EP0540783B1 (en) Catheter
US4285341A (en) Extracorporeal cannula apparatus with retractable intralumenal balloon and method for using same
US4431426A (en) Methods and apparatus for intravenous therapy and hyperalimentation
US5478326A (en) Arterial device for control of bleeding from a puncture in an artery wall
US6500145B1 (en) Retrograde cardioplegia catheter
GB1093867A (en) Catheter
US4944729A (en) Femoral arterial cannula
JPS6279069A (en) Catheter for circulatory system
US9737697B2 (en) Endovascular cerebrospinal fluid shunt
US3109429A (en) Ventriculo-venous shunt device for treatment of hydrocephalus
JP2000300679A (en) Catheter system
US4583967A (en) Telescoping catheter shunt system
BRPI0401080B1 (en) DERIVATION SYSTEM FOR DRAINING FLUID IN A PATIENT AND UNDERSTANDING THE SYSTEM
Nulsen et al. Control of hydrocephalus by valve-regulated shunt